Literature DB >> 14739423

Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study.

Dawn Kleindorfer1, Brett Kissela, Alex Schneider, Daniel Woo, Jane Khoury, Rosemary Miller, Kathleen Alwell, James Gebel, Jerzy Szaflarski, Arthur Pancioli, Edward Jauch, Charles Moomaw, Rakesh Shukla, Joseph P Broderick.   

Abstract

BACKGROUND AND
PURPOSE: Acute ischemic stroke patients are infrequently treated with recombinant tissue plasminogen activator (rtPA). We present unique population-based data regarding the eligibility of ischemic stroke patients for rtPA treatment.
METHODS: All ischemic strokes presenting to an emergency department (ED) within a biracial population of 1.3 million were identified. The patient was considered eligible for rtPA on the basis of exclusion criteria from the National Institute of Neurological Disorders and Stroke rtPA trial.
RESULTS: Of 2308 ischemic strokes, 1849 presented to an ED. Only 22% of all ischemic strokes in the population arrived in the ED in <3 hours from symptom onset; of these, 209 (51%) were ineligible for rtPA on the basis of mild stroke severity, medical and surgical history, or blood tests.
CONCLUSIONS: In our population in 1993 to 1994, 8% of all ischemic stroke patients presented to an ED within 3 hours and met other eligibility criteria for rtPA. Even if time were not an exclusion for rtPA, only 29% of all ischemic strokes in our population would have otherwise been eligible for rtPA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14739423     DOI: 10.1161/01.STR.0000109767.11426.17

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  91 in total

1.  Creating a Novel Video Vignette Stroke Preparedness Outcome Measure Using a Community-Based Participatory Approach.

Authors:  Lesli E Skolarus; Jillian B Murphy; Mackenzie Dome; Marc A Zimmerman; Sarah Bailey; Sophronia Fowlkes; Lewis B Morgenstern
Journal:  Health Promot Pract       Date:  2014-11-03

2.  Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years.

Authors:  Opeolu Adeoye; Richard Hornung; Pooja Khatri; Dawn Kleindorfer
Journal:  Stroke       Date:  2011-06-02       Impact factor: 7.914

Review 3.  Diagnosis and management of acute ischemic stroke: speed is critical.

Authors:  Tapuwa D Musuka; Stephen B Wilton; Mouhieddin Traboulsi; Michael D Hill
Journal:  CMAJ       Date:  2015-08-04       Impact factor: 8.262

4.  Mobile Telestroke During Ambulance Transport Is Feasible in a Rural EMS Setting: The iTREAT Study.

Authors:  Jason M Lippman; Sherita N Chapman Smith; Timothy L McMurry; Zachary G Sutton; Brian S Gunnell; Jack Cote; Debra G Perina; David C Cattell-Gordon; Karen S Rheuban; Nina J Solenski; Bradford B Worrall; Andrew M Southerland
Journal:  Telemed J E Health       Date:  2015-11-24       Impact factor: 3.536

Review 5.  Hyperacute imaging of ischemic stroke: role in therapeutic management.

Authors:  Scott L Selco; David S Liebeskind
Journal:  Curr Cardiol Rep       Date:  2005-01       Impact factor: 2.931

Review 6.  Drug treatment of acute ischemic stroke.

Authors:  Sameer Bansal; Kiranpal S Sangha; Pooja Khatri
Journal:  Am J Cardiovasc Drugs       Date:  2013-02       Impact factor: 3.571

7.  Diagnostic accuracy of whole-brain computed tomography perfusion for detection of ischemic stroke in patients with mild neurological symptoms.

Authors:  Robert A Frank; Santanu Chakraborty; Trevor McGrath; Alexander Mungham; James Ross; Dar Dowlatshahi; Michel Shamy; Grant Stotts
Journal:  Neuroradiol J       Date:  2018-05-03

8.  Strategies to improve acute stroke care of patients in rural and other geographically dispersed areas.

Authors:  R Charles Callison; Enrique C Leira
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

Review 9.  Clinical translation of nitrite therapy for cardiovascular diseases.

Authors:  John W Calvert; David J Lefer
Journal:  Nitric Oxide       Date:  2009-11-10       Impact factor: 4.427

Review 10.  Use of magnetic resonance imaging to predict outcome after stroke: a review of experimental and clinical evidence.

Authors:  Tracy D Farr; Susanne Wegener
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.